Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. hVIVO Share Price
  4. hVIVO Share Regulatory News
  5. Open Orphan

Pin to quick pickshVIVO Regulatory News (HVO)

hVIVO Information

Share Price Information for hVIVO (HVO)

Share Price is delayed by 15 minutes
Get Live Data
8.40    0.00 (0.00%)
Bid:
8.30
Ask:
8.50
Spread: 0.20 (2.41%)
Market Cap: £57.83m
HVO Live PriceLast checked at - London Stock Exchange

Intraday hVIVO Share Chart

Open Orphan

15 Jan 2020 17:30

RNS Number : 9383Z
FTSE Russell
15 January 2020
 

 

 

 

 

Open Orphan (UK): Merger with Hvivo (UK)Changes in FTSE UK Index Series

15 January 2020

Subject to the completion of the merger between Open Orphan (UK, constituent) and Hvivo (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

20 January 2020

 

* The number of shares is based on the merger terms of 2.47 new Open Orphan shares for every Hvivo share held.

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSSFWFIIESSEIF
123456789
Date   Source Headline
1st Jun 202612:00 pmRNS-RConsultancy contract with Decoy Therapeutics
29th May 20267:00 amRNSGrant of awards under Long Term Incentive Plan
20th May 20267:00 amRNSCapital Markets Day
13th May 20261:40 pmRNSResult of AGM
12th May 20269:45 amRNSHolding(s) in Company
7th May 20267:00 amRNS£6m Influenza HCT contract signed
24th Apr 20266:14 pmRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSHCT contract signed with ILiAD Biotechnologies
17th Apr 20267:00 amRNSAnnual Report & Notice of AGM
15th Apr 20267:00 amRNSFinal Results 2025
14th Apr 20267:01 amRNS-RhVIVO launches unified brand identity
14th Apr 20267:00 amRNSInfluenza HCT contract signed with Traws Pharma
7th Apr 20267:00 amRNSNotice of Results
26th Mar 20265:19 pmRNSHolding(s) in Company
27th Feb 20263:31 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSIssue of Equity and Total Voting Rights
16th Feb 20263:05 pmRNSHolding(s) in Company
11th Feb 20263:11 pmRNSHolding(s) in Company
29th Jan 20267:00 amRNSTrading Update
27th Jan 20267:00 amRNSNotice of Trading Update
18th Dec 20257:00 amRNSAppointment of Non-Executive Director
15th Dec 20252:47 pmRNSCEO & CFO Share Purchase
27th Nov 20257:00 amRNS-RMSD to acquire Cidara
20th Nov 20257:00 amRNS>£5 million CRS contracts signed
11th Nov 20257:00 amRNS-RPositive data from novel human challenge models
6th Nov 20255:05 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNS-RPresentation at Jefferies Healthcare Conference
27th Oct 20253:01 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNSInterim results
4th Sep 20257:00 amRNSNotice of Results
1st Sep 20257:00 amRNSAppointment of Non-Executive Chair
29th Jul 20257:00 amRNSProposed appointment of Chair
22nd Jul 20257:00 amRNSH1 Trading update
18th Jul 20257:00 amRNSDirectorate Change
9th Jul 20257:00 amRNSNotice of Trading Update
1st Jul 20254:04 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNS-RPositive results from client Phase 2b field study
5th Jun 20251:00 pmRNSResult of AGM
2nd Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSTrading update
29th May 20257:00 amRNSAppointment of Independent Non-Executive Director
12th May 20257:00 amRNSAnnual Report, Notice of AGM & Directorate Change
10th Apr 20257:05 amRNSExercise of Options
10th Apr 20257:00 amRNSFinal results
26th Mar 20251:51 pmRNSAIM Rule 17 and Schedule 2(g) Update
21st Mar 20257:00 amRNSNotice of Results
7th Mar 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSAcquisition of Cryostore for up to £3.2m
17th Feb 20257:00 amRNS£2m hMPV characterisation study contract
5th Feb 20257:00 amRNS-RShionogi reports positive RSV trial results
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
CEPS
Ceps
LSE
0.00%
VTU
Vertu
LSE
0.00%
EAT
European Assets Trust
LSE
0.00%
EVE
EVE.L
LSE
0.00%
RKMD
Rostelekom Adr
LSE
0.00%
Trending
AVCT
Avacta Group
LSE
2.14%
ALRT
Defence Holdings
LSE
14.29%
PREM
Premier African Minerals
LSE
0.00%
GST
GSTechnologies
LSE
8.11%
LLOY
Lloyds
LSE
-0.52%